The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines [Editorial]

The CORA service is operating as normal. For general information on remote access to UCC Library services and collections during the University closure, please visit the main library website at https://libguides.ucc.ie

Show simple item record

dc.contributor.author Griffin, Brendan T.
dc.contributor.author Dressman, Jennifer B.
dc.date.accessioned 2019-03-15T10:44:25Z
dc.date.available 2019-03-15T10:44:25Z
dc.date.issued 2019-03-03
dc.identifier.citation Griffin, B. T. and Dressman, J. B. (2019) 'The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines', Journal of Pharmacy and Pharmacology, 71(4), pp. 439-440. doi:10.1111/jphp.13083 en
dc.identifier.volume 71 en
dc.identifier.issued 4 en
dc.identifier.startpage 439 en
dc.identifier.endpage 440 en
dc.identifier.issn 0022-3573
dc.identifier.issn 2042-7158
dc.identifier.uri http://hdl.handle.net/10468/7631
dc.identifier.doi 10.1111/jphp.13083
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher John Wiley & Sons, Inc. en
dc.relation.uri https://onlinelibrary.wiley.com/doi/abs/10.1111/jphp.13083
dc.rights © 2019, Royal Pharmaceutical Society of Great Britain. Published by John Wiley & Sons, Inc. All rights reserved. This is the peer reviewed version of the following article: Griffin, B. T. and Dressman, J. B. (2019) 'The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines', Journal of Pharmacy and Pharmacology, 71(4), pp. 439-440. doi:10.1111/jphp.13083, which has been published in final form at https://doi.org/10.1111/jphp.13083. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. en
dc.subject Oral medicine en
dc.subject Solubility en
dc.subject PBPK en
dc.subject Bio-enabling formulation en
dc.title The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines [Editorial] en
dc.type Other en
dc.internal.authorcontactother Brendan Griffin, School Of Pharmacy, University College Cork, Cork, Ireland. +353-21-490-3000 Email: brendan.griffin@ucc.ie en
dc.internal.availability Full text available en
dc.check.info Access to this article is restricted until 12 months after publication by request of the publisher. en
dc.check.date 2020-03-03
dc.date.updated 2019-03-15T10:30:58Z
dc.description.version Accepted Version en
dc.internal.rssid 477599752
dc.contributor.funder Horizon 2020 en
dc.description.status Peer reviewed en
dc.identifier.journaltitle Journal of Pharmacy and Pharmacology en
dc.internal.copyrightchecked Yes en
dc.internal.licenseacceptance Yes en
dc.internal.IRISemailaddress brendan.griffin@ucc.ie en
dc.relation.project info:eu-repo/grantAgreement/EC/H2020::MSCA-ITN-ETN/674909/EU/Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines/PEARRL en


Files in this item

This item appears in the following Collection(s)

Show simple item record

This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement